<code id='B5AD13B2F9'></code><style id='B5AD13B2F9'></style>
    • <acronym id='B5AD13B2F9'></acronym>
      <center id='B5AD13B2F9'><center id='B5AD13B2F9'><tfoot id='B5AD13B2F9'></tfoot></center><abbr id='B5AD13B2F9'><dir id='B5AD13B2F9'><tfoot id='B5AD13B2F9'></tfoot><noframes id='B5AD13B2F9'>

    • <optgroup id='B5AD13B2F9'><strike id='B5AD13B2F9'><sup id='B5AD13B2F9'></sup></strike><code id='B5AD13B2F9'></code></optgroup>
        1. <b id='B5AD13B2F9'><label id='B5AD13B2F9'><select id='B5AD13B2F9'><dt id='B5AD13B2F9'><span id='B5AD13B2F9'></span></dt></select></label></b><u id='B5AD13B2F9'></u>
          <i id='B5AD13B2F9'><strike id='B5AD13B2F9'><tt id='B5AD13B2F9'><pre id='B5AD13B2F9'></pre></tt></strike></i>

          Home / explore / leisure time

          leisure time


          leisure time

          author:leisure time    Page View:47865
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In